What changed
Tempest Therapeutics filed a Form 8-K reporting submission of matters to a vote of security holders, including say-on-pay vote results, with the information disclosed in Item 8.01 incorporated by reference. The filing also reports other events designated as major. No revenue, EPS, or guidance figures were disclosed in the filing text.
Why it matters
Tempest Therapeutics filed a Form 8-K reporting submission of matters to a vote of security holders, including say-on-pay vote results, with the information disclosed in Item 8.01 incorporated by refe